Driver mutational status did not impact overall and leukemia-free survival; conversely, CALR (type 1/1-like more than type 2/2-like) and MPL mutations were significantly associated with a higher risk of MF progression, as previously reported [19, 25, 29–32]. Here, MPL is linked to leukemia.